FDA inspection
Tai Guk Pharm Co., Ltd.: FDA inspection ending Feb 21, 2025
FDA inspection 1261693 · Voluntary Action Indicated (VAI) · Buyeo
Key facts
| Inspection ID | 1261693 |
|---|---|
| Firm | Tai Guk Pharm Co., Ltd. |
| FEI number | 3011346725 |
| Address | 821 Geumbaek-Ro, Chochon-Myeon |
| City | Buyeo |
| Country | Korea (the Republic of) |
| Fiscal year | 2025 |
| Inspection end date | Feb 21, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data